[{"status": "Ongoing", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84122", "recalling_firm": "Sanofi-Aventis U.S. LLC", "address_1": "55 Corporate Dr", "address_2": "", "postal_code": "08807-1265", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0540-2020", "product_description": "Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC 50269-222-25.", "product_quantity": "", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191022", "center_classification_date": "20191201", "report_date": "20191211", "code_info": "all lots", "more_code_info": ""}, {"country": "United States", "city": "East Brunswick", "address_1": "1 Tower Center Blvd Ste 1700", "reason_for_recall": "Lack of Assurance of Sterility: complaints received about dried powder on the outside of bottle", "address_2": "", "product_quantity": "5,060 units", "code_info": "Lot #: VCIA082, Exp. MAY 2020; VCIA083, VCIA084, Exp. JUNE 2020", "center_classification_date": "20190108", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "Cidofovir Injection 375mg/5mL (75mg/mL) vial injection. 5 mL vials, Rx only, Mfd by: Emcure Pharmaceuticals Ltd., Hinjawadi, Pune, India  Mfg. for : Heritage Pharmaceuticals Inc. NDC 23155-0216-31", "report_date": "20190116", "classification": "Class II", "openfda": {}, "recalling_firm": "Heritage Pharmaceuticals, Inc.", "recall_number": "D-0352-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81896", "termination_date": "20210219", "more_code_info": "", "recall_initiation_date": "20190102", "postal_code": "08816-1145", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0435-2020", "product_description": "iSolutions Nano Tears XP Clear Emollient Lubricant Gel Drops Moderate Sterile, 1/3 FL OZ (10 mL), Mfd.  By: Altaire Pharmaceuticals, Inc. Aquebogue, NY 11931, NDC 59390-143-10", "product_quantity": "12,716 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "17366 12/19   18103 /20   18173 7/20"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["ALTALUBE"], "generic_name": ["MINERAL OIL AND PETROLATUM"], "manufacturer_name": ["Altaire Pharmaceuticals Inc."], "product_ndc": ["59390-198"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["MINERAL OIL", "PETROLATUM"], "rxcui": ["579996", "1088146"], "spl_id": ["0c0e9c0d-6205-e63b-e063-6294a90ac0d9"], "spl_set_id": ["eb65004c-c3a7-4079-bd75-f2857d30c68a"], "package_ndc": ["59390-198-50"], "is_original_packager": [true], "unii": ["T5L8T28FGP", "4T6H12BN9U"]}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0418-2020", "product_description": "ActivEyes Sterile Altalube Ointment, Net Wt 1/8 oz (3.5g), NDC 59390-198-50", "product_quantity": "161077 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "RJH 10/20 1/10/2018   RLL 12/20 8/22/2018   SGH 07/21 8/23/2018   SIF 09/21 10/16/2018   SKC 11/21 12/12/2018   TCG 03/22"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82398", "recalling_firm": "Advanced Pharma Inc.", "address_1": "9265 Kirby Dr", "address_2": "N/A", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1031-2019", "product_description": "Heparin 5,000 Units/5mL (1,000 Units per mL) Injectable Solution, 5,000 Units in 0.9% Sodium Chloride, QS 5 mL Sterile single use syringe, NDC: 42852-739-67 Avella of Houston 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404", "product_quantity": "1440 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190313", "center_classification_date": "20190321", "termination_date": "20200114", "report_date": "20190327", "code_info": "Lot: 10/25/18 4819 73967S Exp. 3/24/2019"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0784-2019", "product_description": "Dr. King's SafeCare Rx CA Miasm, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955030027, NDC 57955-0300-2", "product_quantity": "146 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 033016H Exp. 03/19; 121216D Exp. 12/19"}, {"status": "Terminated", "city": "Gulfport", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83835", "recalling_firm": "GCP Laboratories Inc", "address_1": "3600 25th Ave", "address_2": "N/A", "postal_code": "39501-6922", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed in MI and further distributed Nationwide.", "recall_number": "D-0126-2020", "product_description": "Major Infants' Gas Relief Drops, Simethicone Oral Suspension USP, 1 FL OZ (30 mL) bottle, Distributed by: Major Pharmaceuticals 17177 N Laurel Park Drive, Suite 233 Livonia, MI 48152 USA. NDC 0904-5894-30", "product_quantity": "31,392 30 mL bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Product.", "recall_initiation_date": "20190918", "center_classification_date": "20191007", "termination_date": "20210205", "report_date": "20191016", "code_info": "Lot: WBD003 Exp. 03/21"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83875", "recalling_firm": "Sandoz, Inc", "address_1": "506 Carnegie Ctr Ste 400", "address_2": "N/A", "postal_code": "08540-6243", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0127-2020", "product_description": "Sandoz Ranitidine Hydrochloride Capsules 150mg 60 Capsules Rx Only Manufactured by Sandoz Inc. Princeton, NJ  Product of India  NDC 0781-2855-60", "product_quantity": "100,314 bottles", "reason_for_recall": "CGMP Deviations: Detection of a trace amount of an unexpected impurity, N-nitrosodimethylamine (NDMA).", "recall_initiation_date": "20190923", "center_classification_date": "20191007", "termination_date": "20230714", "report_date": "20191016", "code_info": "HC9266 4/30/2020   HD1865 4/30/2020  HP9441 9/30/2020  JK7994 8/31/2021  JK8659 8/31/2021"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0084-2020", "product_description": "Phenylephrine HCl 1.5% (15 mg/mL) Lidocaine HCl 1% (10 mg/mL) (PF) (Sulfite Free) Ophthalmic Injection, 3 mL Single Dose Syringe, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678441", "product_quantity": "825 syringe", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0080-2020", "product_description": "NORepinephrine in 0.9% Sodium Chloride (PF), 250 mL IV bag, 4 mg/250 mL (0.016 mg/mL),  Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487, NDC 3321678032", "product_quantity": "528 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0257-2020", "product_description": "S-VITAMIN D3 10,000 IU/ML OIL MDV INJ, Rx Only, a) 5ml b) 10 ML glass vial. Red Mountain Compounding Rx.", "product_quantity": "16x5 and 10 ml glass vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #:  S04092019DT@16, Exp 8/9/19; S05012019DT@08, Exp 9/1/19; S05152019DT@01, Exp 9/15/19; S06112019DH@18, Exp 10/11/19; S06122019DT@06, Exp 10/12/19; S06192019DT@10, Exp 10/19/19; s07092019dt@16, Exp 11/9/19; S07242019DH@10, Exp 11/24/19"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0792-2019", "product_description": "Dr. King's SafeCare Rx Artery/Cholesterol/BP, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955006428, NDC 57955-0064-2", "product_quantity": "544 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 092915G Exp. 09/18; 041416F Exp. 04/19"}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1704-2019", "product_description": "SODIUM BICARBONATE 8.4% (1 MEQ/ML) INJ SOLN (PFV), 50 ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0957-50", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Tarrytown", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83417", "recalling_firm": "Medtech Products, Inc.", "address_1": "660 White Plains Rd Ste 250", "address_2": "N/A", "postal_code": "10591-5171", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico, St. Michael, Barbados, Guyana, St. Johns, Antigua and Barbuda, Kingston 5, and Jamaica.", "recall_number": "D-1828-2019", "product_description": "Clear Eyes Assorted Sidekick Floor Stand Display; each display contains 6 each of a) Clear eyes REDNESS RELIEF (Glycerin 0.25%, Naphazoline hydrochloride 0.12%) eye drops, 0.5 FL OZ (15 mL) bottle (UPC 6 78112 25415 6); b) Clear eyes MAXIMUM REDNESS RELIEF (Glycerin 0.5%, Naphazoline hydrochloride 0.03%), 0.5 FL OZ (15 mL) bottle (UPC 6 78112 66577 8); and c) Clear eyes MAXIMUM ITCHY EYE RELIEF (Glycerin 0.25%, Naphazoline hydrochloride 0.012%, Zinc Sulfate 0.25%), 0.5 FL OZ (15 mL) bottle (UPC 6 78112 65920 3); Distributed by Medtech Products Inc., Tarrytown, NY  10591, A Prestige Brands Company, case UPC 00678112106905.", "product_quantity": "25,992 bottles", "reason_for_recall": "CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.", "recall_initiation_date": "20190726", "center_classification_date": "20190816", "termination_date": "20210310", "report_date": "20190828", "code_info": "Lot #: Display 17E12A, Exp 09/19; lot and expiry for individual products within this display are captured in each individual product Code Information"}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1745-2019", "product_description": "Abraxane 170 MG / 34 ML IVPB; Abraxane 200 MG / 40 ML IVPB; Abraxane 180 MG / 36 ML IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"country": "United States", "city": "Sugar Land", "address_1": "1075 W Park One Dr Ste 100", "reason_for_recall": "Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules", "address_2": "", "product_quantity": "", "code_info": "Lots: 10029291 Exp. 11/14/2019    10029292 Exp. 11/14/2019    10029977 Exp. 11/20/2019  10030041 Exp. 11/21/2019  10029977 Exp. 11/20/2019    10029978 Exp. 11/21/2019    10029979 Exp. 11/21/2019    10030041 Exp. 11/21/2019    10030043 Exp. 11/21/2019    10030396 Exp. 11/25/2019    10030960 Exp. 12/2/2019    10030961 Exp. 12/4/2019    10030962 Exp. 12/4/2019    10031010 Exp. 12/4/2019    10031011 Exp. 12/4/2019    10031012 Exp. 12/4/2019    10030960 Exp. 12/2/2019    10031086 Exp. 12/6/2019    10030960 Exp. 12/2/2019  10031263 Exp. 12/10/2019    10031262 Exp. 12/10/2019    10031413 Exp. 12/15/2019    10031463 Exp. 12/16/2019    10031696 Exp. 12/22/2019    10031947 Exp. 12/26/2019    10031948 Exp. 12/31/2019  10032414 Exp. 1/2/2020    10031978 Exp. 1/1/2020    10031948 Exp. 12/31/2019    10032412 Exp. 1/2/2020    10032413 Exp. 1/2/2020    10032687 Exp. 1/8/2020    10032723 Exp. 1/9/2020    10033037 Exp. 1/23/2020    10032929 Exp. 1/26/2020", "center_classification_date": "20191203", "distribution_pattern": "Nationwide.", "state": "TX", "product_description": "fentaNYL 200 mcg/100 mL (2 mcg/mL) ROPivacaine HCl 0.2% 200 mg/100 mL (2 mg/mL) in 0.9% Sodium Chloride , 100 mL bag, Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478  NDC 70092-1108-36", "report_date": "20191211", "classification": "Class II", "openfda": {}, "recalling_firm": "QuVa Pharma, Inc.", "recall_number": "D-0561-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84263", "termination_date": "20200605", "more_code_info": "", "recall_initiation_date": "20191112", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Charlotte", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82620", "recalling_firm": "CMC Enterprise Pharmacy", "address_1": "4400 Golf Acres Dr", "address_2": "N/A", "postal_code": "28208-5968", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NC", "recall_number": "D-1226-2019", "product_description": "CeFAZolin 3 gm 100 mg/mL, 30 mL syringe, Made by: Enterprise Pharmacy, 4400 Golf Acres Drive, Bldg. J Suite E, Charlotte, NC, 28208.", "product_quantity": "475 syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190412", "center_classification_date": "20190423", "termination_date": "20191030", "report_date": "20190501", "code_info": "Lots: EB281907 Exp. 4/14/2019; EC011905 Exp. 4/15/2019; EC071907 Exp. 4/21/2019; EC081908 Exp. 4/22/2019; EC131906 Exp. 4/27/2019; EC141906 Exp. 4/28/2019; EC151919 Exp. 4/29/2019; EC181907 Exp. 5/2/2019; EC201906 Exp. 5/4/2019; EC211907 Exp. 5/5/2019; EC221908 Exp. 5/6/2019; EC251907 Exp. 5/9/2019; EC261907 Exp. 5/10/2019; EC271907 Exp. 5/11/2019; EC281907 Exp. 5/12/2019; EC011907 Exp. 5/16/2019; ED021909 Exp. 5/17/2019; ED031907 Exp. 5/18/2019; ED041906 Exp. 5/19/2019; ED051908 Exp. 5/20/2019; ED081907 Exp. 5/23/2019; ED091907 Exp. 5/24/2019"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0834-2019", "product_description": "Dr. King's SafeCare Rx Acid Clenz, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955012726, NDC 57955-0127-2", "product_quantity": "133 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 050216U Exp. 05/19; 072716C Exp. 07/19"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0237-2020", "product_description": "S-MAGNESIUM CHLORIDE 200MG/ML MDV INJ, 30 ml vial, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #:  S07162019DH@15, Exp 8/16/19"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0571-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Hemorrhoid Relief, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955502326, NDC 57955-5023-2", "product_quantity": "2045 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 012317C Exp. 01/20; 052516U Exp. 05/19; 050216S Exp. 05/19"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "82092", "recalling_firm": "Akorn Inc", "address_1": "1925 W Field Ct Ste 300", "address_2": "", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, including Puerto Rico.", "recall_number": "D-0515-2019", "product_description": "Clobetasol Propionate Emollient Cream 0.05%, a) 30 gram (NDC 50383-270-30) and b) 60 gram (NDC 50383-270-60) tubes, Rx only. Manufacturer: Akorn Inc. 369 Bayview Ave., Amityville, NY 117701.", "product_quantity": "a) 4896 tubes; b) 5064 tubes", "reason_for_recall": "Failed Stability Specification; out of specification (OOS) results for a preservative at 9 month stability study.", "recall_initiation_date": "20190125", "center_classification_date": "20190220", "termination_date": "20201103", "report_date": "20190227", "code_info": "a) 357052, exp 4/19/19  b) 356892, exp 4/16/19 and 356927, exp 4/15/19", "more_code_info": ""}, {"status": "Terminated", "city": "Roseburg", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81883", "recalling_firm": "Hiers Enterprises, LLC dba Northwest Compounding Pharmacy", "address_1": "1350 Ne Stephens St Ste 42", "address_2": "N/A", "postal_code": "97470-6410", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed exclusively in the state of Oregon to 3 Medical facilities, 1 Physician's office and 80 consumers/patients.    These are compounded products - labels vary for each compound - specific to each patient.  Firm did not provide labeling.", "recall_number": "D-0400-2019", "product_description": "Methocarbamol liquid 100mg/ml, RX, glass vial", "product_quantity": "300 ml", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190102", "center_classification_date": "20190127", "termination_date": "20230328", "report_date": "20190109", "code_info": "10082018@34 exp 1/6/19,    10312018@27 exp 1/29/19"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83437", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide within the United States and Brazil and on the internet", "recall_number": "D-1595-2019", "product_description": "Dragon Pain Oil, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.", "recall_initiation_date": "20190712", "center_classification_date": "20190802", "termination_date": "20230613", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1816-2019", "product_description": "VELCADE 2.1 mg / 0.84 ml SQ SYRINGE; VELCADE 2.5 MG/ 1 ML SUB-Q SYRINGE; VELCADE 2.2 MG/ 0.88 ML SUB-Q SYRINGE; VELCADE 2.6 MG (1.04 ML) Sub Q SYRINGE; VELCADE 4 mg / 1.6 ml SQ SYRINGE; VELCADE 2.75 mg / 1.1 ml SQ SYRINGE; VELCADE 2.6 mg / 1.04 ml SQ SYRINGE  VELCADE 1.7 mg / 0.68 ml SQ SYRINGE; VELCADE 3.5 mg / 1.4 ML SQ SYRINGE; VELCADE 2.2 mg / 0.88 ml SQ SYRINGE; VELCADE 2.33 MG/ 0.93 ML SUB-Q SYRINGE; VELCADE 2.4 MG/ 0.96 ML SUB-Q SYRINGE  VELCADE 2.63 MG/ 1.052 ML SUB-Q SYRINGE, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Colonia", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83427", "recalling_firm": "Colonia Care Pharmacy", "address_1": "515 Inman Ave Ste A", "address_2": "N/A", "postal_code": "07067-1114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Patient Specific Prescriptions in NJ", "recall_number": "D-0034-2020", "product_description": "C-VERAPAMIL 2.5MG/ML INJ SOLN, 10 mL vial, Rx only, Colonia Care Pharmacy, 515 Inman Ave., Suite A, Colonia, N.J. 07067", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility: product sterility cannot be guaranteed.", "recall_initiation_date": "20190724", "center_classification_date": "20191001", "termination_date": "20230405", "report_date": "20191009", "code_info": "Lot #: 072319A, BUD 09/06/19"}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1156-2019", "product_description": "Heparin 20,000 U/Lidocaine 2% 10 mL/Sodium Bicarbonate 8.4% 10 mL/Sterile Water 5 mL, 27 mL Syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "2 syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.", "address_2": "", "product_quantity": "672 bags", "code_info": "Lots: 12/14/18 1482 70399P, BUD: 02/27/19; 12/14/18 1610 70399P, BUD: 02/27/19", "center_classification_date": "20190215", "distribution_pattern": "Nationwide in the USA.", "state": "TX", "product_description": "Oxytocin 20 Units added to NS 1000 mL (oxytocin and 0.9% Sodium Chloride) Injectable Solution, Approximately 1002 mL Sterile single use bag, Rx only,  Avella of Houston, 9265 Kirby Dr., Houston, TX 77054, NDC 42852-703-99.", "report_date": "20190227", "classification": "Class III", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0498-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "82089", "termination_date": "20191030", "more_code_info": "", "recall_initiation_date": "20190206", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Colonia", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83427", "recalling_firm": "Colonia Care Pharmacy", "address_1": "515 Inman Ave Ste A", "address_2": "N/A", "postal_code": "07067-1114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Patient Specific Prescriptions in NJ", "recall_number": "D-0030-2020", "product_description": "C-PAPAV/PHENTOL/PGE1 30MG/2MG/20MCG/ML, 5 mL vial, Rx only, Colonia Care Pharmacy, 515 Inman Ave., Suite A, Colonia, N.J. 07067", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility: product sterility cannot be guaranteed.", "recall_initiation_date": "20190724", "center_classification_date": "20191001", "termination_date": "20230405", "report_date": "20191009", "code_info": "Lot #: 070319A, BUD 08/17/19"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83710", "recalling_firm": "Atlas Pharmaceuticals, LLC", "address_1": "711 E Carefree Hwy Ste 107", "address_2": "N/A", "postal_code": "85085-0103", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Healthcare facilities/clinics in AZ and CO", "recall_number": "D-0144-2020", "product_description": "Ascorbic Acid Sterile Injection Solution, 500 mg/mL, 50 mL vial, Non-Corn Source, Rx only, Atlas Pharmaceuticals, LLC, 711 E Carefree Hwy, Suite 107, Phoenix, AZ  85085, NDC 71591-500-50.", "product_quantity": "1646 vials", "reason_for_recall": "Labeling: Not Elsewhere Classified; product is labeled as \"Non-Corn Source\" however the product is from a corn source.", "recall_initiation_date": "20190828", "center_classification_date": "20191015", "termination_date": "20200603", "report_date": "20191023", "code_info": "Lot #: S-60162, BUD 10/12/2019; S-60176, BUD 11/2/2019; S-60187, BUD 11/11/2019; S-60189, BUD 11/16/2019; S-60190, BUD 11/16/2019; S-60222, BUD 01/20/2020"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065259"], "brand_name": ["CEFDINIR"], "generic_name": ["CEFDINIR"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-722", "68180-723"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEFDINIR"], "rxcui": ["309054", "476576"], "spl_id": ["b32b7bfb-4770-4da0-8c48-684233cd10c9"], "spl_set_id": ["7490df67-56c0-4a1c-8533-2107f3e8aea5"], "package_ndc": ["68180-722-20", "68180-722-10", "68180-722-04", "68180-722-05", "68180-723-20", "68180-723-10", "68180-723-04", "68180-723-05"], "is_original_packager": [true], "upc": ["0368180723042"], "nui": ["N0000175488", "M0003827"], "pharm_class_epc": ["Cephalosporin Antibacterial [EPC]"], "pharm_class_cs": ["Cephalosporins [CS]"], "unii": ["CI0FAO63WC"]}, "product_type": "Drugs", "event_id": "81888", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "111 S Calvert St Fl 21ST", "address_2": "", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0376-2019", "product_description": "Cefdinir for Oral Suspension USP, 250mg/5mL, packaged in a) 60mL (NDC 68180-723-20), b)100mL (NDC 68180-723-10), Rx Only, Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, MD 21202; Manufactured by: Lupin Limited Mandideep 462 046 INDIA", "product_quantity": "287,784 bottles", "reason_for_recall": "CGMP Deviations: Product complaints received indicating reconstituted suspension was observed to be thick.", "recall_initiation_date": "20190102", "center_classification_date": "20190115", "termination_date": "20200626", "report_date": "20190116", "code_info": "a) Lot #: F700343, F700344, F700345, F700346, F700347,F700376, F700377, F700415, F700146,F700417, F700418, Exp. Jan 2019;   F700419, F700420, F700492, F700493,F700508,F700665, Exp. February 2019; F700784, Exp. April 2019;     b) Lot #: F700324, F700325, F700326, Exp. January 2019; F700618, F700619, F700620, Exp. February 2019.", "more_code_info": ""}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0367-2020", "product_description": "Equate Restore PM Nighttime Lubricant Eye Ointment, Sterile, Net Wt. 0.125 oz. (3.5g), Distributed by: Walmart Stores Inc., Bentonville, AR 72716, W-M item #551282425, NDC 49035-191-50", "product_quantity": "1537130 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot #: SKG,Exp  08/21; SHK, Exp 08/21; SHJ, Exp 08/21; SEC, Exp 05/21; SCB, Exp 03/21; SBC, Exp 02/21; RLB, Exp 12/20; RBB, Exp 02/20; RHR, Exp 08/20; RFK, Exp 06/20; RAB, Exp 01/20; TAD, Exp 01/22; TAQ, Exp 01/22; TBI, Exp 02/22; TDB, Exp 04/22; QHE, Exp 08/19; QJD, Exp 10/19; SGE, Exp 07/21"}, {"status": "Terminated", "city": "Westbury", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83181", "recalling_firm": "P & L Developments,  LLC", "address_1": "200 Hicks St", "address_2": "N/A", "postal_code": "11590-3323", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1409-2019", "product_description": "Cetirizine Oral Solution 1 mg/mL, Up & Up, Children's allergy relief, Antihistamine, Dye Free, Grape Flavor, 4 FL. oz. (118 mL) Bottle, Distributed by Target Corporation, Minneapolis, MN 55403, NDC 11673-178-04, UPC 359726178044.", "product_quantity": "124,512 bottles", "reason_for_recall": "cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).", "recall_initiation_date": "20190605", "center_classification_date": "20190620", "termination_date": "20200909", "report_date": "20190626", "code_info": "Lot #s: A98495; C03882; A49664, Exp. 5/19; C06541, Exp. 6/19; C05532; F00527, Exp. 10/19; F00528; F07279, Exp. 12/19; F07842; F10237, Exp. 2/20."}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0638-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Fears & Nightmares, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955509929, NDC 57955-5099-2", "product_quantity": "275 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 052616F Exp. 05/19; 063015C Exp. 06/18; 102816K Exp. 10/19"}, {"status": "Ongoing", "city": "Piscataway", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203835"], "brand_name": ["LOSARTAN POTASSIUM"], "generic_name": ["LOSARTAN POTASSIUM"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "product_ndc": ["31722-700", "31722-701", "31722-702"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LOSARTAN POTASSIUM"], "rxcui": ["979480", "979485", "979492"], "spl_id": ["40b34aeb-20b5-4200-e063-6394a90a96e9"], "spl_set_id": ["cafd54e8-42a8-474c-8ea8-49ec74c2b0d3"], "package_ndc": ["31722-700-30", "31722-700-60", "31722-700-90", "31722-700-05", "31722-700-10", "31722-701-30", "31722-701-60", "31722-701-90", "31722-701-05", "31722-701-10", "31722-702-30", "31722-702-60", "31722-702-90", "31722-702-05", "31722-702-10"], "is_original_packager": [true], "upc": ["0331722702300", "0331722700900", "0331722701303"], "unii": ["3ST302B24A"]}, "product_type": "Drugs", "event_id": "82281", "recalling_firm": "Camber Pharmaceuticals Inc", "address_1": "1031 Centennial Ave", "address_2": "N/A", "postal_code": "08854-4125", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1043-2019", "product_description": "Losartan Potassium Tablets USP, 100 mg, Rx only, a) 30 count (NDC 31722-702-30), b) 90 count (NDC 31722-702-30), c) 1000 count (NDC 31722-702-10) bottles, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854 By: Hetero Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar -509 301, India", "product_quantity": "683,641 bottles", "reason_for_recall": "CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) detected in the active pharmaceutical ingredient", "recall_initiation_date": "20190228", "center_classification_date": "20190321", "report_date": "20190327", "code_info": "a) LOP17011, Exp Aug-19, Lot LOP17087 Exp Nov-19;    b) LOP17012, LOP17013, Exp Aug-19, LOP17042, LOP17043 Exp Oct-19,  LOP17044, LOP17045, Exp  Nov-19, LOP18024, LOP18025, LOP18026, LOP18027, LOP18028, LOP18029, LOP18030, Exp. Dec-19;    c) LOP17005, Exp May-19,  LOP17014, Exp Aug-19, LOP17016,  LOP17023, Exp Sep-19, LOP17083, Exp Oct-19, LOP17084, LOP17085, LOP17086, Exp Nov-19, LOP18021, LOP18022, LOP18023, LOP18031, LOP18032, LOP18033, LOP18050, LOP18051, Exp Dec-19, LOP18109,  LOP18111, Exp Mar-20, LOP18122, LOP18123, LOP18124, LOP18125,  LOP18126, LOP18127, LOP18128, LOP18129, LOP18130, LOP18131C, LOP18133, Exp Jun-20"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82593", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1276-2019", "product_description": "GlipiZIDE Extended-release Tablets, 2.5 mg, 30 Tablets (3 x 10), Rx Only, Packaged and Distributed by:  American Health Packaging, Columbus, Ohio 43217.  NDC: 68084-295-21", "product_quantity": "2,203 cartons (cartons of 30 individual unit doses)", "reason_for_recall": "Failed Dissolution Specifications: dissolution failure at time zero of the repackaged lot. Drug release results were slightly above specification at time zero.", "recall_initiation_date": "20190408", "center_classification_date": "20190510", "termination_date": "20201106", "report_date": "20190508", "code_info": "Lot # 181288, EXP 5/31/2020"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82316", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1047-2019", "product_description": "Valsartan Tablets USP 160 mg, 100 Tablets (10 x 10)  per Unit Dose Blisters, Rx Only, Packaged and Distributed by:  American Health Packaging, Columbus, Ohio 43217 (Individual Dose NDC:60687-139-11, Carton NDC#: 60687-139-01)", "product_quantity": "3337 cartons", "reason_for_recall": "CGMP Deviation: Presence of NDEA (N-Nitrosodimethylamine), a carcinogen impurity, detected in the active ingredient.", "recall_initiation_date": "20190306", "center_classification_date": "20190321", "termination_date": "20200909", "report_date": "20190327", "code_info": "Lot 179791, Mar 2020"}, {"status": "Terminated", "city": "Levittown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82889", "recalling_firm": "Torrent Pharma Inc", "address_1": "2091 Hartel Ave", "address_2": "N/A", "postal_code": "19057-4506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.", "recall_number": "D-1373-2019", "product_description": "Lactulose Solution, USP 10 g/15 mL, For Oral or Rectal Administration, Rx Only, 16 FL. oz. Bottle, NDC:13668-574-10, Manufactured By Bio-Pharm, Levittown, PA 19057, Manufactured for Torrent Pharma Inc., Basking Ridge, NJ 07920.", "product_quantity": "153.540 bottles", "reason_for_recall": "cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).", "recall_initiation_date": "20190521", "center_classification_date": "20190613", "termination_date": "20201006", "report_date": "20190619", "code_info": "Lot #s: 18E016; 18E029, Exp. 05/2020; 18F004; 18F005; 18F039, Exp. 06/2020; 18G010; 18G017, Exp. 07/2020; 18H019, Exp. 08/2020; 18M008, Exp. 12/2020; 19A005, Exp. 01/2021; 19B010, Exp. 02/2021."}, {"country": "United States", "city": "Sugar Land", "address_1": "1075 W Park One Dr Ste 100", "reason_for_recall": "Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules", "address_2": "", "product_quantity": "", "code_info": "Lots: 10029972 Exp. 11/21/2019,  10030562 Exp. 11/28/2019,  10031447 Exp. 12/15/2019,  10031341 Exp. 12/15/2019,  10031630 Exp. 12/19/2019,  10031748 Exp. 12/22/2019,  10032817 Exp. 1/8/2020,  10033208 Exp. 1/19/2020,  10032887 Exp. 1/12/2020", "center_classification_date": "20191203", "distribution_pattern": "Nationwide.", "state": "TX", "product_description": "fentaNYL 800 mcg/200 mL (4 mcg/mL) BUPivacaine HCl 0.1667% 333.4 mg/200 mL (1.667 mg/mL) in 0.9% Sodium Chloride 200 mL in 250 mL CADD Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478  NDC 70092-1436-76", "report_date": "20191211", "classification": "Class II", "openfda": {}, "recalling_firm": "QuVa Pharma, Inc.", "recall_number": "D-0568-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84263", "termination_date": "20200605", "more_code_info": "", "recall_initiation_date": "20191112", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202223"], "brand_name": ["VALSARTAN"], "generic_name": ["VALSARTAN"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["65862-570", "65862-571", "65862-572", "65862-573"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VALSARTAN"], "rxcui": ["349199", "349200", "349201", "349483"], "spl_id": ["7b329c09-5c17-4117-9cef-a383ecec90d9"], "spl_set_id": ["a81a72dd-e828-4208-af9b-bb9ac4938537"], "package_ndc": ["65862-570-30", "65862-570-99", "65862-570-10", "65862-571-90", "65862-571-99", "65862-571-10", "65862-572-90", "65862-572-99", "65862-572-10", "65862-573-90", "65862-573-05"], "is_original_packager": [true], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81887", "recalling_firm": "Aurobindo Pharma USA Inc.", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed to 25 distributors and Retail Chains who may have further distributed the product throughout the United States.", "recall_number": "D-0370-2019", "product_description": "Valsartan tablets USP 320 mg, 90-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-573-90.", "product_quantity": "20,604 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.", "recall_initiation_date": "20181231", "center_classification_date": "20190114", "report_date": "20190123", "code_info": "Lot # VUSD17008-A, exp. date 07/2019  Lot # VUSD17009-A, exp. date 09/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1813-2019", "product_description": "SOLIRIS 1200 MG QS 240 ML NACL0.9% IVPB; SOLIRIS 900 MG QS 180 ML NACL 0.9% IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"country": "United States", "city": "East Windsor", "address_1": "279 Princeton Hightstown Rd", "reason_for_recall": "Discoloration; Hazy solution found in one vial instead of a clear solution.", "address_2": "", "product_quantity": "59,500 vials", "code_info": "Lot CFD190004, exp. date August 2020", "center_classification_date": "20191209", "distribution_pattern": "Product was distributed to major wholesalers/distributors who may have further distribute the product throughout the United States.", "state": "NJ", "product_description": "Fluphenazine Decanoate Injection USP 125mg/5mL, (5 mL Multiple Dose Vial), Rx only, For IM or SC Use, Mfd in India for: AuroMedics Pharma, LLC, E. Windsor, NJ", "report_date": "20191211", "classification": "Class II", "openfda": {}, "recalling_firm": "AuroMedics Pharma LLC", "recall_number": "D-0609-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84244", "termination_date": "20210121", "more_code_info": "", "recall_initiation_date": "20191112", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0700-2019", "product_description": "Dr. King's SafeCare Rx Allergies Plains U.S., 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955260226, NDC 57955-2720-2", "product_quantity": "150 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 010118E Exp. 01/20; 011917M Exp. 01/20"}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1175-2019", "product_description": "Sermorelin 0.3 mg/0.5 mL, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "22 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0230-2020", "product_description": "S-HYDROXOCOBALAMIN 10MG/ML MDV INJ SOL, 30 ML glass vial, Red Mountain Compounding Rx.", "product_quantity": "2x30 glass vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #:S07242019DH@05, Exp 10/24/19"}, {"status": "Terminated", "city": "Dayton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83581", "recalling_firm": "Aurolife Pharma, LLC", "address_1": "2400 US Highway 130", "address_2": "N/A", "postal_code": "08810-1519", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1874-2019", "product_description": "Allergy (Fexofenadine Hydrochloride) Tablets USP, 180 mg, 30-count cartons, DISCOUNT drug mart FOOD FAIR, Distributed by: Discount Drug Mart, 211 Commerce Drive, Medina, OH  44256, NDC 53943-021-09.", "product_quantity": "4536 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20190823", "center_classification_date": "20190917", "termination_date": "20220816", "report_date": "20190925", "code_info": "Lot #: 067180024B1, Exp 07/21"}, {"status": "Terminated", "city": "Beloeil", "state": "N/A", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84055", "recalling_firm": "8046255 Canada Inc. DBA Viatrexx", "address_1": "1360 Louis-Marchand St", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed to physicians Nationwide throughout the United States and Puerto Rico.", "recall_number": "D-0328-2020", "product_description": "Viatrexx-Ouch, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0500, NDC 73069-402-41.", "product_quantity": "19 vials", "reason_for_recall": "Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.", "recall_initiation_date": "20191015", "center_classification_date": "20191114", "termination_date": "20201210", "report_date": "20191120", "code_info": "Lot Numbers: 19-S00003, Exp. May: 2020"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065022"], "brand_name": ["POLYCIN"], "generic_name": ["BACITRACIN ZINC AND POLYMYXIN B SULFATES"], "manufacturer_name": ["Padagis US LLC"], "product_ndc": ["0574-4021"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["BACITRACIN ZINC", "POLYMYXIN B SULFATE"], "rxcui": ["213621", "308511"], "spl_id": ["64c51556-c8f4-4f2e-987c-13825419f833"], "spl_set_id": ["3abbfb58-26d1-460d-a60f-db63c0193a0d"], "package_ndc": ["0574-4021-35"], "is_original_packager": [true], "unii": ["89Y4M234ES", "19371312D4"]}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0355-2020", "product_description": "Polycin (bacitracin zinc and polymyxin B sulfate) Ophthalmic Ointment USP, Net. Wt. 3.5 g (1/8 oz.), Rx only,  Manufactured for Perrigo, Minneapolis, MN 55427, NDC 0574-4021-35", "product_quantity": "261,528 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot#: RGD, Exp 7/19; RHL, Exp 8/19; RHB, Exp 9/19; RJF, Exp 10/19; RJG, Exp 10/19; SAJ, Exp 1/20; SAK, Exp 1/20; SAL, Exp 1/20; SAM, Exp 1/20; SBK, Exp 2/20; SEH, Exp 5/20; TCD, Exp 1/21"}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81810", "recalling_firm": "Promise Pharmacy, LLC", "address_1": "31818 Us Highway 19 N", "address_2": "N/A", "postal_code": "34684-3713", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0481-2019", "product_description": "Folic Acid, 5mg/ml injection, 10ml vial, Rx Only, Promise Pharmacy Compounding Specialists 31818 US Hwy 19N, Palm Harbor, FL 34684", "product_quantity": "1 10 ml vial", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20181217", "center_classification_date": "20190208", "termination_date": "20210330", "report_date": "20190220", "code_info": "Lot: 10302018@8, BUD 12/14/2018"}, {"status": "Terminated", "city": "Belleville", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83316", "recalling_firm": "US Pharmaceuticals Inc.", "address_1": "681 Main St Ste 27", "address_2": "N/A", "postal_code": "07109-3471", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1737-2019", "product_description": "CRYO-273 Cold Pain Relieving Gel Roll-On 3 FL. OZ. (89 mL) Distributed By: CRYO-273.com Tampa, FL 33629. UPC 8 15290 01529 6", "product_quantity": "167 cases", "reason_for_recall": "CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.", "recall_initiation_date": "20190711", "center_classification_date": "20190813", "termination_date": "20200625", "report_date": "20190821", "code_info": "Lot #'s 09K17, 13K17 EXP 08/2019"}, {"status": "Terminated", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83996", "recalling_firm": "Coast Quality Pharmacy, LLC dba Anazao Health", "address_1": "5710 Hoover Blvd", "address_2": "N/A", "postal_code": "33634-5339", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0584-2020", "product_description": "Bupivacaine HCL and Clonidine HCL and Hydromorphone HCL and Fentanyl Citrate in all strengths, all doses and all packaging, AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634.", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.", "recall_initiation_date": "20190903", "center_classification_date": "20191206", "termination_date": "20201201", "report_date": "20191218", "code_info": "All lots filled and dispensed on 08/26-29/2019 and 09/27/2019 through 10/03/2019 remaining within expiry.", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0847-2019", "product_description": "Dr. King's SafeCare Rx First Aid for Mind & Body, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955177029, NDC 57955-1770-2", "product_quantity": "1229 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 072815Q Exp. 07/18; 081815E Exp. 08/18; 091216F Exp. 09/19; 071317A Exp. 07/19"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81344", "recalling_firm": "Bound Tree Medical, LLC", "address_1": "1420 Lakeside Parkway", "address_2": "N/A", "postal_code": "75208", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0383-2019", "product_description": "curaplex Epi Safe Administration and Training Kits, #8600-01100, Contains: 2 Epi Safe Administration Kit (8600-01101), 1 Epi Safe Training Kit (8600-01102), Rx Only, Distributed by Sarnova HC, LLC s family of companies: Bound Tree Medical, LLC, Cardio Partners, Inc., Emergency Medical Products, Inc. &  Tri-anim Health Services, Inc. 5000 Tuttle Crossing Blvd. Dublin, OH 43016", "product_quantity": "1,283 kits (8 syringes per kit / 3 IFU's per kit)", "reason_for_recall": "Labeling Incorrect Instructions:  This recall has been initiated because the Instructions for Use included in the Epi-Safe Kits for the Epi-Safe Syringe (and/or the Safety Lok Syringe in Model 8600-01120) recommend a midpoint dosage of epinephrine for children between 0 lbs. and 66 lbs. of 0.15mL that has not been approved by FDA for children. Reliance on the current IFU and/or use of the Epi-Safe Syringe as instructed may result in the administration of an inappropriate dosage of epinephrine to young children experiencing anaphylaxis, especially those under 33 lbs. Additionally the Epi Safe syringe does not have the correct markings to allow a health care provider to draw up the correct dosage for children under 33 kg.", "recall_initiation_date": "20181102", "center_classification_date": "20190118", "termination_date": "20200605", "report_date": "20190130", "code_info": "all lot numbers"}, {"status": "Terminated", "city": "Beloeil", "state": "N/A", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84055", "recalling_firm": "8046255 Canada Inc. DBA Viatrexx", "address_1": "1360 Louis-Marchand St", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed to physicians Nationwide throughout the United States and Puerto Rico.", "recall_number": "D-0326-2020", "product_description": "Viatrexx-Connectissue, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0090, NDC 73069-100-41.", "product_quantity": "24 vials", "reason_for_recall": "Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.", "recall_initiation_date": "20191015", "center_classification_date": "20191114", "termination_date": "20201210", "report_date": "20191120", "code_info": "Lot Numbers: 19-S00001, Exp. May: 2020"}, {"status": "Terminated", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84422", "recalling_firm": "Preferred Pharmaceuticals, Inc", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "N/A", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "CA, FL", "recall_number": "D-0617-2020", "product_description": "Ranitidine Tablets, USP 150 mg, OTC, a.) 30 count bottle (NDC 68788-7078-03), b.) 60 count bottle (NDC 68788-7078-06), Mfg: Amneal Pharmaceuticals", "product_quantity": "316 bottles", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191202", "center_classification_date": "20191209", "termination_date": "20230509", "report_date": "20191218", "code_info": "Lot #: I2519H, Exp. 12/20; I2719O, Exp. 12/20; J1419O, Exp. 12/20; J2819L, Exp. 12/20", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83875", "recalling_firm": "Sandoz, Inc", "address_1": "506 Carnegie Ctr Ste 400", "address_2": "N/A", "postal_code": "08540-6243", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0128-2020", "product_description": "Sandoz Ranitidine Hydrochloride Capsules 150mg 500 Capsules Rx Only Manufactured by Sandoz Inc. Princeton, NJ 08540 Product of India NDC 0781-2855-05", "product_quantity": "13,130 bottles", "reason_for_recall": "CGMP Deviations: Detection of a trace amount of an unexpected impurity, N-nitrosodimethylamine (NDMA).", "recall_initiation_date": "20190923", "center_classification_date": "20191007", "termination_date": "20230714", "report_date": "20191016", "code_info": "HD1862 4/30/2020  HP9438 9/30/2020  HP9439 9/30/2020  HP9440 9/30/2020"}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1701-2019", "product_description": "RIBOFLAVIN 0.1% OPHTHALMIC SOLUTION SYRINGE, 2 ML per syringe. RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0923-02", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0810-2019", "product_description": "Dr. King's SafeCare Rx Leg Cramps & Spasms, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955043522, NDC 57955-0435-2", "product_quantity": "296 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 072015J Exp. 07/18; 051716H Exp. 05/19; 081016B Exp. 08/19; 092617B Exp. 10/19"}, {"status": "Ongoing", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84122", "recalling_firm": "Sanofi-Aventis U.S. LLC", "address_1": "55 Corporate Dr", "address_2": "", "postal_code": "08807-1265", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0542-2020", "product_description": "Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219.     NDC's   67751-152-01  67751-152-02", "product_quantity": "", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191022", "center_classification_date": "20191201", "report_date": "20191211", "code_info": "all lots", "more_code_info": ""}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82196", "recalling_firm": "Macleods Pharma Usa Inc", "address_1": "666 Plainsboro Rd Bldg 200 Ste 230", "address_2": "N/A", "postal_code": "08536-0009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1005-2019", "product_description": "Telmisartan and Hyrdochlorothiazide Tablets 80 mg/25 mg, 30-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Manufactured by: Macleods Pharmaceuticals Ltd. Baddi Himachal Pradesh, INDIA, NDC 33342-130-07", "product_quantity": "134495 bottles", "reason_for_recall": "Failed Content Uniformity Specifications: The product is out of specification for blend uniformity.", "recall_initiation_date": "20190225", "center_classification_date": "20190314", "termination_date": "20210712", "report_date": "20190320", "code_info": "Lot #: BTN703A, BTN704A Exp Feb-19; BTN705A, BTN706A, Exp May-19; BTN707A, Exp Jun-19; BTN810A, Exp Jun-20;  BTN811A, BTN812A Exp Aug-20; BTN813A, BTN814A, Exp Sep-20; BTN802A, BTN802B, BTN803A, BTN804A, Exp Dec-19; BTN805A, BTN806A, BTN807A, BTN807B, Exp Feb-20;  BTN808A, Exp Apr-20; BTN809A, BTN810A,  Exp Jun-20; BTN811A, BTN812A, Exp Aug-20; BTN813A, BTN814A, Exp Sep-20."}, {"status": "Terminated", "city": "Chino", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82857", "recalling_firm": "La Fresh Group, Inc.", "address_1": "4651 Schaefer Ave", "address_2": "N/A", "postal_code": "91710-5542", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Firm's website sales and www.Amazon.com", "recall_number": "D-1566-2019", "product_description": "LA FRESH travel lite Sunnyside Lotion Wipe silky, non-greasy formula smooth, soft & moisturizing featuring titanium dioxide, 1 wipe individually wrapped packet, 4.75\" x 5.75\" (12.0 cm x 14.6 cm) Ingredients: Water, Dimethicone, Dimethiconol, Titanium Dioxide, Benzophenone-3, Octinoxate, Ethylhexylglycerine, Phenoxyethanol, Distributed by La Fresh Group, Inc. Chino, CA 91710 www.LaFreshGroup.com", "product_quantity": "83,050 packets", "reason_for_recall": "Marketed without an Approved NDA/ANDA: The product may be construed a sunscreen due to labeling of the product and comments about the product found on e-commerce websites.", "recall_initiation_date": "20190715", "center_classification_date": "20190731", "termination_date": "20210409", "report_date": "20190731", "code_info": "All lots beginning with 453091"}, {"status": "Terminated", "city": "Levittown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82889", "recalling_firm": "Torrent Pharma Inc", "address_1": "2091 Hartel Ave", "address_2": "N/A", "postal_code": "19057-4506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.", "recall_number": "D-1378-2019", "product_description": "Hemorrhoidal Suppositories (Phenylephrine HCl 0.25%; Hard Fat 88.7%), 12 Rectal Suppositories per carton, NDC: 0536-1389-12, Distributed by Rugby Laboratories, Livonia MI 48152 USA.", "product_quantity": "82,872 bottles", "reason_for_recall": "cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).", "recall_initiation_date": "20190521", "center_classification_date": "20190613", "termination_date": "20201006", "report_date": "20190619", "code_info": "Lot #s: 17L008, Exp. 05/2019; 17M019; 17M037, Exp. 06/2019; 18B012; 18K023, Exp. 04/2020."}, {"status": "Ongoing", "city": "Basking Ridge", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82585", "recalling_firm": "Torrent Pharma Inc.", "address_1": "150 Allen Rd Ste 102", "address_2": "N/A", "postal_code": "07920-3856", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1118-2019", "product_description": "Losartan Potassium / Hydrochlorothiazide Tablets, USP 100mg/12.5mg,  a) 30-count (NDC: 13668-117-30), b) 90-count (NDC: 13668-117-90) per bottle , Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana India.  For: Torrent Pharma, Inc, 150 Allen Road, Suite 102, Basking Ridge, NJ", "product_quantity": "172,296 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA)  in the finished product above the interim acceptable daily intake level.", "recall_initiation_date": "20190228", "center_classification_date": "20190410", "report_date": "20190417", "code_info": "Count, lots, expiry: [30-count bottle] Lot BEF8D058,exp 11/30/2020 [90-count bottle] Lots BEF8D009, BEF8D010, BEF8D011, BEF8D012, BEF8D013,   BEF8D007, BEF8D008, exp 3/31/2020; Lots BEF8D023, BEF8D024, BEF8D025, BEF8D020, BEF8D021, BEF8D022, exp 4/30/2020; Lots BEF8D054, BEF8D055, BEF8D056, exp 10/31/2020; Lots BEF8D057, exp 11/30/2020"}, {"status": "Ongoing", "city": "Basking Ridge", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82585", "recalling_firm": "Torrent Pharma Inc.", "address_1": "150 Allen Rd Ste 102", "address_2": "N/A", "postal_code": "07920-3856", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1119-2019", "product_description": "Losartan Potassium / Hydrochlorothiazide Tablets, USP 100mg/25mg,  a) 30-count (NDC: 13668-118-30), b) 90-count (NDC: 13668-118-90), c) 1000-count (NDC: 13668-118-10) per bottle , Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana India.  For: Torrent Pharma, Inc, 150 Allen Road, Suite 102, Basking Ridge, NJ", "product_quantity": "173,760 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA)  in the finished product above the interim acceptable daily intake level.", "recall_initiation_date": "20190228", "center_classification_date": "20190410", "report_date": "20190417", "code_info": "Count, lots, expiry: [30-count bottle] Lot BEF6D038, exp 4/30/2020; [90-count bottle] Lots BEF6D030, BEF6D031, exp 4/30/2020; Lots BEF6D047,   BEF6D048, BEF6D049, BEF6D050, BEF6D051, exp 7/31/2020; Lots BEF6D082, BEF6D083, BEF6D084, BEF6D085, BEF6D086, BEF6D087, exp 10/31/2020; Lots 4P04E003, 4P04E004, 4P04E005, 4P04E006, exp 1/31/2021; [1000-count bottle] 4P04E007, 4P04E008, 4P04E009, exp 1/31/2021"}, {"status": "Terminated", "city": "Corvallis", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82278", "recalling_firm": "Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy", "address_1": "996 Nw Circle Blvd Ste 105", "address_2": "N/A", "postal_code": "97330-1485", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed in Oregon", "recall_number": "D-1091-2019", "product_description": "PGE1 40 MCG/ML* INJECTABLE, (2) 5ml (b) 10ml, (c) 6ml (d) 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .", "product_quantity": "5 prescriptions 5,10, 6, 9 ml injectable", "reason_for_recall": "Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.", "recall_initiation_date": "20190221", "center_classification_date": "20190409", "termination_date": "20200723", "report_date": "20190417", "code_info": "Lot:(a) 10102018@30, (b) 31102018@33,05112018@1, (c)15012019@8, (d)  30012019@33,  distributed between 09-01-2018 to 02-20-2019."}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0902-2019", "product_description": "Aquaflora Phase I Candida Control Program, Net 16 fl. oz. (1 PT) 473 mL, Homeopathic Formula, Manufactured by: King Bio, Inc. 3 Westside Dr. Asheville, NC 28806 USA, UPC 357955160168, NDC 57955-1601-6", "product_quantity": "6153 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 022218D Exp. 02/20; 100917D Exp. 10/19; 021717A Exp. 02/20; 041816B Exp. 04/19; 062816F Exp. 06/19; 122815B Exp. 12/18"}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1715-2019", "product_description": "TURBO DROPS (PHEN 2.5% / CYCLO 1%/ TROP 1%/ KETO 0.5%) OPHTH SOLN, 5 ML per dropper bottle, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0205-05", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0623-2019", "product_description": "Dr. King's Natural Medicine Homeopathic ClaustroPlex, 2 fl. oz. (59 mL), King Bio, Inc. 3 Westside Dr. Asheville, NC 28806, UPC 357955503521,  NDC 57955-5035-2", "product_quantity": "34 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 021016J Exp. 02/19; 063016H Exp. 06/19"}, {"status": "Terminated", "city": "Miami Lakes", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83190", "recalling_firm": "Pharma-Natural Inc.", "address_1": "14500 Nw 60th Ave Bldg 7f", "address_2": "N/A", "postal_code": "33014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Consignees in FL and TX who may have further distributed Nationwide in the USA and Puerto Rico.", "recall_number": "D-1503-2019", "product_description": "Dayma SUPER FORTE XL10 (Camphor 0.5%, Menthol 2%, Methyl Salicylate 2%) Pain Relieving Topical Analgesic Gel, 4 Oz (113.4 g) jar, Distributed by: Biosfera International Distribution, LLC., Miami Lakes, FL 33016, NDC 63788-118-04.", "product_quantity": "1000 jars", "reason_for_recall": "CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.", "recall_initiation_date": "20190621", "center_classification_date": "20190723", "termination_date": "20211027", "report_date": "20190731", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0667-2019", "product_description": "Dr. King's Natural Medicine for kids! Attention & Learning Enhancement Homeopathic, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside dr. Asheville, NC 28806 USA, UPC 357955501527, NDC 57955-5015-2", "product_quantity": "1083 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 050216G Exp. 05/2016; 070816C Exp. 07/2019; 092617F Exp. 09/2019"}, {"status": "Terminated", "city": "Roseburg", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81883", "recalling_firm": "Hiers Enterprises, LLC dba Northwest Compounding Pharmacy", "address_1": "1350 Ne Stephens St Ste 42", "address_2": "N/A", "postal_code": "97470-6410", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed exclusively in the state of Oregon to 3 Medical facilities, 1 Physician's office and 80 consumers/patients.    These are compounded products - labels vary for each compound - specific to each patient.  Firm did not provide labeling.", "recall_number": "D-0397-2019", "product_description": "Lidocaine gel 2%, RX, plastic dropper", "product_quantity": "125 ml", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190102", "center_classification_date": "20190127", "termination_date": "20230328", "report_date": "20190109", "code_info": "10222018@15"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0689-2019", "product_description": "Dr. King's SafeCare Rx Children's Fever Reliever Children High Potency Homeopathic Formula for Professional Use Only, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806 USA, UPC 357955015925, NDC 57955-0176-2", "product_quantity": "95 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 082516A Exp. 08/2019; 102015F Exp. 10/2018"}, {"status": "Terminated", "city": "Corvallis", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82278", "recalling_firm": "Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy", "address_1": "996 Nw Circle Blvd Ste 105", "address_2": "N/A", "postal_code": "97330-1485", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed in Oregon", "recall_number": "D-1104-2019", "product_description": "PAPAVERINE-PHENTOLAMINE-PGE1 17.64-0.58MG-5.88MCG/ML* INJECTABLE, 9 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .", "product_quantity": "1 prescription 9ml injection", "reason_for_recall": "Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.", "recall_initiation_date": "20190221", "center_classification_date": "20190409", "termination_date": "20200723", "report_date": "20190417", "code_info": "Lot:17012019@18, distributed between 09-01-2018 to 02-20-2019."}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0102-2020", "product_description": "Sodium Citrate 40 mg/mL (4%) / Gentamicin 0.32 mg/mL. 30 mL vial for Intra-Catheter Use Only, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321676603", "product_quantity": "150 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84213", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed Nationwide throughout the United States, Canada and Saudi Arabia", "recall_number": "D-0503-2020", "product_description": "Silicea 6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV  25411, barcode 7 40640 64199 6.", "product_quantity": "426 bottles", "reason_for_recall": "CGMP Deviations: products were not manufactured under current good manufacturing practices.", "recall_initiation_date": "20191108", "center_classification_date": "20191118", "termination_date": "20230104", "report_date": "20191127", "code_info": "Lot #: BR18B278"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84213", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed Nationwide throughout the United States, Canada and Saudi Arabia", "recall_number": "D-0502-2020", "product_description": "Natrum Sulphuricum  6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV  25411, barcode 7 40640 64193 4.", "product_quantity": "288 bottles", "reason_for_recall": "CGMP Deviations: products were not manufactured under current good manufacturing practices.", "recall_initiation_date": "20191108", "center_classification_date": "20191118", "termination_date": "20230104", "report_date": "20191127", "code_info": "Lot #: BR18C280"}, {"country": "United States", "city": "Sugar Land", "address_1": "1075 W Park One Dr Ste 100", "reason_for_recall": "Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules", "address_2": "", "product_quantity": "", "code_info": "Lot: 10031855 Exp. 12/24/2019", "center_classification_date": "20191203", "distribution_pattern": "Nationwide.", "state": "TX", "product_description": "fentaNYL 550 mcg/55 mL (10 mcg/mL) in 0.9% Sodium Chloride 55 mL Syringe Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478  NDC 70092-1274-50", "report_date": "20191211", "classification": "Class II", "openfda": {}, "recalling_firm": "QuVa Pharma, Inc.", "recall_number": "D-0572-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84263", "termination_date": "20200605", "more_code_info": "", "recall_initiation_date": "20191112", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Tarrytown", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83417", "recalling_firm": "Medtech Products, Inc.", "address_1": "660 White Plains Rd Ste 250", "address_2": "N/A", "postal_code": "10591-5171", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico, St. Michael, Barbados, Guyana, St. Johns, Antigua and Barbuda, Kingston 5, and Jamaica.", "recall_number": "D-1832-2019", "product_description": "Clear Eyes Maximum Itchy Eye Relief Sidekick Floor Stand Display; each display (case UPC 10678112736383) contains 12 each of Clear eyes MAXIMUM ITCHY EYE RELIEF (Glycerin 0.25%, Naphazoline hydrochloride 0.012%, Zinc Sulfate 0.25%) eye drops, 0.5 FL OZ (15 mL) bottle, (UPC 6 78112 65920 3), Distributed by Medtech Products Inc., Tarrytown, NY  10591, A Prestige Brands Company.", "product_quantity": "1,836 bottles", "reason_for_recall": "CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.", "recall_initiation_date": "20190726", "center_classification_date": "20190816", "termination_date": "20210310", "report_date": "20190828", "code_info": "Lot #: 16331, 16344, Exp 12/19"}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1681-2019", "product_description": "MIC B12 W/B6 (LIPOSTAT PLUS) 25/50/50/1/.175 MG/ML, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0978-30", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"country": "United States", "city": "Sugar Land", "address_1": "1075 W Park One Dr Ste 100", "reason_for_recall": "Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules", "address_2": "", "product_quantity": "", "code_info": "Lots: 10029361 Exp. 11/15/2019,    10029362 Exp. 11/15/2019,    10029334 Exp. 11/14/2019,    10029855 Exp. 11/19/2019,  10029856 Exp. 11/19/2019,  10030387 Exp. 11/25/2019,    10030388 Exp. 11/25/2019,    10031026 Exp. 12/12/2019,    10031078 Exp. 12/12/2019,  10031469 Exp. 12/16/2019,  10031493 Exp. 12/16/2019,    10031519 Exp. 12/17/2019,    10031804 Exp. 12/23/2019,    10031105 Exp. 12/12/2019,  10031830 Exp. 12/23/2019,    10031884 Exp. 12/24/2019,    10032704 Exp. 1/8/2020,  10032888 Exp. 1/12/2020,    10032889 Exp. 1/12/2020,  10032913 Exp. 1/13/2020,    10032939 Exp. 1/13/2020,  10032940 Exp. 1/13/2020", "center_classification_date": "20191203", "distribution_pattern": "Nationwide.", "state": "TX", "product_description": "fentaNYL 400 mcg/200 mL (2 mcg/mL) ROPivacaine HCl 0.1% 200 mg/200 mL (1 mg/mL) in 0.9% Sodium Chloride 200 mL CADD, Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478   NDC 70092-1441-76", "report_date": "20191211", "classification": "Class II", "openfda": {}, "recalling_firm": "QuVa Pharma, Inc.", "recall_number": "D-0564-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84263", "termination_date": "20200605", "more_code_info": "", "recall_initiation_date": "20191112", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0659-2019", "product_description": "Dr. King's Kids Bed Wetting Homeopathic, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806 USA, UPC 357955501220, NDC 57955-0447-2", "product_quantity": "600 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 101615B Exp. 10/2018; 111717C Exp. 11/2019"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0860-2019", "product_description": "Dr. King's SafeCare Rx Environmental Adaptation: Weather Changes, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955028727, NDC 57955-0287-2", "product_quantity": "198 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 072516M Exp. 07/19; 082615B Exp. 08/18"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0490-2020", "product_description": "Clear Eyes Redness Relief (Little Drug),Product Size: 0.2 FL. Oz., UPC#: 7-92554-70103-7", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot #: 16321, Exp 11/19; 16336, Exp 12/19; 17012, Exp 1/20; 17034, Exp 2/20; 17051, Exp 2/20; 17147, Exp 5/20"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0911-2019", "product_description": "NET Remedies #1 Homeopathic Preparation, Oral Liquid, 57 mL, Manufacturer: King Bio Inc. U.S.A., Supplier: NET (Australia) Pty LTD 428 Hume Street, Toowoomba QLD 4350, Australia", "product_quantity": "2600 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: AUS-091515A Exp. 09/18; AUS-081516H Exp. 08/19; AUS-050516A Exp. 05/19; AUS-030816A Exp. 03/19; AUS-011117A Exp. 01/20; AUS-011916A Exp. 01/19"}, {"status": "Terminated", "city": "Levittown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82889", "recalling_firm": "Torrent Pharma Inc", "address_1": "2091 Hartel Ave", "address_2": "N/A", "postal_code": "19057-4506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.", "recall_number": "D-1346-2019", "product_description": "Children's Acetaminophen Liquid, 160 mg per 5 mL, Fever and Pain, Alcohol free, aspirin free, ibuprofen free, Cherry Flavor, 4 FL. oz. (118 mL) bottle, NDC: 59741-101-06, Manufactured by Bio-Pharm, Inc., Levittown PA 19057, Assured.", "product_quantity": "58,272 bottles", "reason_for_recall": "cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).", "recall_initiation_date": "20190521", "center_classification_date": "20190613", "termination_date": "20201006", "report_date": "20190619", "code_info": "Lot #: 17E035, Exp. 05/2019"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0946-2019", "product_description": "NET Remedies #7 Flora Plus Homeopathic Preparation, Oral Liquid, 57 mL, NDC 57955-4207-2", "product_quantity": "9888 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: NR-090115K Exp. 09/18; NR-031516G Exp. 03/19; NR-011216E Exp. 10/19; NR-021717D Exp. 02/20; NR-042717C Exp. 04/20; NR-061616F Exp. 06/19; NR-090616F Exp. 09/19; NR-101416G Exp. 10/19; NR-120815M Exp. 12/18; NR-020118H Exp. 02/20; NR-020618J Exp. 02/20; NR-081017H Exp. 08/19; NR-101117E Exp. 10/19"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0101-2020", "product_description": "Sodium Bicarbonate 8.4%, 4,200 mg / 50 mL 50 mEq / 50 mL (84 mg/mL) (1 mEq/mL), 50 mL Fill in a 60 mL Single Dose Syringe, For IV Use, Rx Only KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321674199", "product_quantity": "540 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0464-2020", "product_description": "Natural Ophthalmics Ortho-K Thin Eye Drops, 15 mL,  NDC 68770-144-15", "product_quantity": "84216 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "17375 12/19  17376 12/19  18190 7/20  18191 8/20"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078921"], "brand_name": ["ANASTROZOLE"], "generic_name": ["ANASTROZOLE"], "manufacturer_name": ["BluePoint Laboratories"], "product_ndc": ["68001-155"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ANASTROZOLE"], "rxcui": ["199224"], "spl_id": ["2dc9d4ae-4fbc-df45-e063-6394a90a09a0"], "spl_set_id": ["3cd04ed6-7c5a-4c4a-9955-ee40839dfea0"], "package_ndc": ["68001-155-04", "68001-155-08"], "is_original_packager": [true], "upc": ["0368001155045"], "nui": ["N0000175563", "N0000175080"], "pharm_class_epc": ["Aromatase Inhibitor [EPC]"], "pharm_class_moa": ["Aromatase Inhibitors [MoA]"], "unii": ["2Z07MYW1AZ"]}, "product_type": "Drugs", "event_id": "83290", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-1467-2019", "product_description": "Anastrozole Tablets, USP, 1 mg, a) 30-count (NDC 68001-155-04) and 1000-count (NDC 68001-155-08) bottles, Rx Only, Manufactured by:  Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories", "product_quantity": "375,921 bottles", "reason_for_recall": "GMP Deviations: Potential cross contamination due to cleaning procedure failure.", "recall_initiation_date": "20190509", "center_classification_date": "20190710", "termination_date": "20200909", "report_date": "20190717", "code_info": "Count, Lot, Expiry:  [30-count bottle]  Lots M711214, M711215, M711216, M711217, exp 8/31/2019; Lots M802198,   M802199, exp 1/31/2020; Lots M805203, M805204, M805207, exp 3/31/2019; Lots M812455, exp 6/30/2020; Lot M815766, exp 9/30/2020; Lots M818633,   M818634, exp 10/31/2020; Lots M819858, M819859, exp 11/30/2020      [1000-count bottle] Lot M711218, exp 8/31/2019; Lot M802197, exp 1/31/2020; Lots M805209, M805946, exp 3/31/2020; Lot M812456, exp 6/30/2020; Lots M815767, M818273, exp 9/30/2020; Lot M819857, exp 11/30/2020", "more_code_info": ""}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0363-2020", "product_description": "Walgreen's Lubricant Eye Ointment, Mineral Oil 42.5%/White Petrolatum 57.3% /Eye Lubricant, Net Wt. 0.125 oz. (3.5g), Distributed by: Walgreen Co., 200 Wilmot Rd, Deerfield, IL 60015, Item #801486, NDC 0363-0191-50", "product_quantity": "45672 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot #: TDB, Exp 4/22"}, {"status": "Terminated", "city": "Charlotte", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "82246", "recalling_firm": "Golean Detox US", "address_1": "4832 Central Ave", "address_2": "N/A", "postal_code": "28205-5844", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1009-2019", "product_description": "Golean DETOX capsules, 14 Net: 56 g, 14 packets containing 2 capsules per packet, 28-count capsules per box, MAT XI S.G Co., LTD, Head office: J29 Vo Thi Sau Street, Thong Nhat Ward, Bien Hoa City, Dong Nai Province, Viet Nam; Manufactory: 148/9 Tan Tien Ward, Bien Hoa City, Dong Nai Province, Viet Nam; Product distribution franshise by GoLean Detox Enterprise 002677155-A Malaysia, www.matxisg.com, UPC 8 938510 909013.", "product_quantity": "37 boxes", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: FDA analysis found product to contain undeclared sibutramine and phenolphthalein. Sibutramine is an appetite suppressant that was withdrawn from the US market due to safety concerns. Phenolphthalein was once an ingredient used in over-the-counter laxatives, but because of concerns of carcinogenicity is not currently approved for marketing in the US. The presence of sibutramine and phenolphthalein in this product renders it an unapproved drug for which the safety and efficacy has not been established and, therefore, subject to recall.", "recall_initiation_date": "20190222", "center_classification_date": "20190318", "termination_date": "20210126", "report_date": "20190320", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0042-2020", "product_description": "Bacteriostatic Water for Injection, 30 mL Vial, Rx Only, KRS Global Biotechnology791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321674177", "product_quantity": "6568 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0663-2019", "product_description": "Dr. King's Natural Medicine for kids! Children's Fever Reliever Homeopathic, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside dr. Asheville, NC 28806 USA, UPC 357955515920, NDC 57955-5159-2", "product_quantity": "873 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 021216H Exp. 02/2019; 052616H Exp. 05/2019; 102815C Exp. 10/2018; 120816A Exp. 12/2019"}, {"status": "Terminated", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209204"], "brand_name": ["IBUPROFEN"], "generic_name": ["IBUPROFEN"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["51672-1385"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["IBUPROFEN"], "rxcui": ["197803"], "spl_id": ["39628a1c-56a6-3f83-e063-6394a90a8c98"], "spl_set_id": ["a8b46ae5-67bc-494d-850e-b4e4ed5a33b3"], "package_ndc": ["51672-1385-8", "51672-1385-9"], "is_original_packager": [true], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["WK2XYI10QM"]}, "product_type": "Drugs", "event_id": "83887", "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "address_1": "3 Skyline Dr", "address_2": "", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0299-2020", "product_description": "Ibuprofen Oral Suspension USP, 100 mg/5 mL, One Pint, (473 mL), Rx only, Manufactured by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Distributed by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1385-9", "product_quantity": "639,325 bottles", "reason_for_recall": "Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.", "recall_initiation_date": "20190927", "center_classification_date": "20191105", "termination_date": "20230831", "report_date": "20191106", "code_info": "Lot #: J78402968, J784129698, Exp 9/19; K765129698, K765229698, K765329698, K769329698, K778829698, K778929698, Exp 10/19; A887230568, A887330568, A887430568, Exp 12/19; B865430568, B865530568, B865630568, B869530568, B869630568, Exp 1/20; D866431198, D866531198, D866631198, D866731198, D866831198, D866931198, D872631198, D872731198, D872831198, D872931198, D873031834, Exp 3/20; E875331834, E875431834, E883831834, E883931834, E884031834, E884131834, Exp 4/20; F865131834, Exp 5/20; G879432436, G879532436, G879632436, G879732436, G879832436, G879932436, G881632436, G882232436, Exp 6/20; H865232436, H865332436, H870832436, Exp 7/20; I885233156, I885333156, I885433156, I885533156, I885633156, I885733164, Exp 8/20; J868533164, J868633164, J868733164, J868833164, J868933164 and J869033164, Exp 9/20; L866434042, L866534043, L866634044, L866734045, L866834046, L866934422, Exp 11/20; A973134748, A973234423, A973334424, A979534425, A979634426, A979734427, A979834428, Exp 12/20; B974034749, B974134750, B974234751, B974334752, B974434753, Exp 1/21", "more_code_info": ""}, {"status": "Terminated", "city": "Littleton", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83397", "recalling_firm": "Wise Pharmacy", "address_1": "6179 S Balsam Way Ste 150", "address_2": "N/A", "postal_code": "80123-3095", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CO, TX, WY", "recall_number": "D-1567-2019", "product_description": "Acetylcysteine 2% Otic Drop, 15 mL bottle, Rx only, Refrigerate, Compounded by Wise Pharmacy, Littleton, CO 80123.", "product_quantity": "1 bottle", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20190722", "center_classification_date": "20190731", "termination_date": "20200203", "report_date": "20190807", "code_info": "Lot #: 7131N, Exp 7/11/19"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0793-2019", "product_description": "Dr. King's SafeCare Rx Heartburn Relief, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955002222, NDC 57955-0022-2", "product_quantity": "245 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 041416B Exp. 04/19; 091416K Exp. 09/19"}, {"country": "United States", "city": "East Windsor", "address_1": "279 Princeton Hightstown Rd", "reason_for_recall": "CGMP Deviations: N-nitrosodimethylamine (NDMA) has been detected in Ranitidine tablets, capsules and syrups.", "address_2": "", "product_quantity": "19320 bottles", "code_info": "UI1519001-A  UI1519002-A  UI1519003-A  UI1519004-A", "center_classification_date": "20191126", "distribution_pattern": "nationwide", "state": "NJ", "product_description": "Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL (75 mg/5mL) 474 mL bottle, Rx only Distributed by: Aurobindo Pharma USA Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India  NDC 65862-431-74", "report_date": "20191204", "classification": "Class II", "openfda": {}, "recalling_firm": "AuroMedics Pharma LLC", "recall_number": "D-0529-2020", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "84218", "more_code_info": "", "recall_initiation_date": "20191106", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81810", "recalling_firm": "Promise Pharmacy, LLC", "address_1": "31818 Us Highway 19 N", "address_2": "N/A", "postal_code": "34684-3713", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0477-2019", "product_description": "Lysine HCl, 100 mg/mL injection, 10ml, Rx Only, Promise Pharmacy Compounding Specialists 31818 US Hwy 19N, Palm Harbor, FL 34684", "product_quantity": "11 10 ml vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20181217", "center_classification_date": "20190208", "termination_date": "20210330", "report_date": "20190220", "code_info": "Lot: 11132018@8 BUD: 12/28/2018"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "81796", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "111 S Calvert St Fl 21ST", "address_2": "", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico.", "recall_number": "D-0355-2019", "product_description": "Ceftriaxone for Injection USP, 250 mg, packaged in a) one Single Use Vial (NDC 68180-611-01) and b) 10 Single Use Vials per box (NDC 68180-611-10); Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., 111 South Calvert Street, Baltimore, Maryland  21202; Manufactured by: Lupin Limited, Mandideep 462 046 INDIA.", "product_quantity": "a) 12,000 vials; b) 11,763 boxes", "reason_for_recall": "Presence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted vials.", "recall_initiation_date": "20181220", "center_classification_date": "20190114", "termination_date": "20200818", "report_date": "20190116", "code_info": "Lot #: a) C600142, Exp 08/19; b) C600136, Exp 08/19; C600182, Exp 09/19, C700147, Exp 05/20; C700207, Exp 09/20  Additional lots added 12/19/2018 - C600142, C700147 and C700207", "more_code_info": ""}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83437", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide within the United States and Brazil and on the internet", "recall_number": "D-1602-2019", "product_description": "Herpes-S, 500 mg Capsules, 90-count bottles, Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.", "recall_initiation_date": "20190712", "center_classification_date": "20190802", "termination_date": "20230613", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Levittown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82889", "recalling_firm": "Torrent Pharma Inc", "address_1": "2091 Hartel Ave", "address_2": "N/A", "postal_code": "19057-4506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.", "recall_number": "D-1368-2019", "product_description": "Cough Syrup (Guaifenesin Syrup, USP) 200 mg/10 mL, Alcohol free Non-Narcotic Expectorant, One Pint (473 mL) oz. bottle, NDC: 0536-0825-85, Distributed by Rugby Laboratories, Livonia, MI 48152.", "product_quantity": "249,744 bottles", "reason_for_recall": "cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).", "recall_initiation_date": "20190521", "center_classification_date": "20190613", "termination_date": "20201006", "report_date": "20190619", "code_info": "Lot #s: 17F022, Exp. 06/2019; 17G027, Exp. 07/2019; 17H021; 17H021A, Exp. 08/2019; 17J008, Exp. 09/2019; 17L001, Exp. 11/2019; 17M015, Exp. 12/2019; 18A018, Exp. 01/2020; 18B003; 18B008, Exp. 02/2020; 18C012, Exp. 03/2020; 18D005, Exp. 04/2020; 18F008; 18F043, Exp. 06/2020; 18G025; 18H004, Exp. 07/2020; 18H007; 18H016, Exp. 08/2020."}]